- Home
- AVAV vs ASND Comparison
AVAV vs ASND Comparison
Compare AVAV & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAV
- ASND
- Stock Information
- Founded
- AVAV 1971
- ASND 2006
- Country
- AVAV United States
- ASND Denmark
- Employees
- AVAV N/A
- ASND N/A
- Industry
- AVAV Aerospace
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- AVAV Industrials
- ASND Health Care
- Exchange
- AVAV Nasdaq
- ASND Nasdaq
- Market Cap
- AVAV 18.9B
- ASND 12.2B
- IPO Year
- AVAV 2007
- ASND 2015
- Fundamental
- Price
- AVAV $329.65
- ASND $197.74
- Analyst Decision
- AVAV Strong Buy
- ASND Strong Buy
- Analyst Count
- AVAV 13
- ASND 17
- Target Price
- AVAV $349.23
- ASND $245.76
- AVG Volume (30 Days)
- AVAV 944.4K
- ASND 377.7K
- Earning Date
- AVAV 12-03-2025
- ASND 11-12-2025
- Dividend Yield
- AVAV N/A
- ASND N/A
- EPS Growth
- AVAV N/A
- ASND N/A
- EPS
- AVAV N/A
- ASND N/A
- Revenue
- AVAV $1,085,820,000.00
- ASND $576,332,355.00
- Revenue This Year
- AVAV $148.47
- ASND $104.98
- Revenue Next Year
- AVAV $17.12
- ASND $79.91
- P/E Ratio
- AVAV N/A
- ASND N/A
- Revenue Growth
- AVAV 44.03
- ASND 54.50
- 52 Week Low
- AVAV $102.25
- ASND $118.03
- 52 Week High
- AVAV $417.86
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- AVAV 40.80
- ASND 45.06
- Support Level
- AVAV $359.08
- ASND $196.86
- Resistance Level
- AVAV $378.25
- ASND $209.00
- Average True Range (ATR)
- AVAV 18.26
- ASND 6.83
- MACD
- AVAV -8.77
- ASND -0.98
- Stochastic Oscillator
- AVAV 26.80
- ASND 26.31
About AVAV AeroVironment Inc.
AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.